本網站使用瀏覽器紀錄 (Cookies) 來提供您最好的使用體驗，我們使用的 Cookie 也包括了第三方 Cookie。相關資訊請訪問我們的隱私權與 Cookie 政策。如果您選擇繼續瀏覽或關閉這個提示，便表示您已接受我們的網站使用條款。 關閉
SHANGHAI, Jan. 31, 2024 /PRNewswire/ -- With the new favorable policy of encouraging the innovative development of advanced medical devices from the Guidance Catalogue for Industrial Structure Adjustment (2024), which announced by the National Development and Reform Commission , it indicates that the medical device industry of China has entered a booming period of innovative development and high-quality development in 2024. Medtec China 2024 will kick off at the Shanghai World Expo Exhibition & Convention Center on September 25-27, which will cover an area of 42,000 square meters, 1,000+ exhibitors and 80,000+ expected visits. The ADTE (Advanced Active Device Tech EXPO) and Quality Expo will be concurrently hosted to help medical device enterprises to find new opportunities in cutting-edge trends of the industry. 21 categories of exhibits including R&D and Design services, materials, adhesives and adhesive products, components, electronic components, motors and motion control, pumps and valves, filters and IV products , etc. The Early Bird Pricing of exhibit is available until January 31st. Click here to grab limited seats and open new market! The Concurrently - held Three Exhibitions Shape a New Pattern, with 16 Themed Zones Covering Focuses of Medical Device Sector On the 20th anniversary of Medtec entering the Chinese market, Medtec China 2024 will open up the tracks of advanced active device and quality testing. Fully tapping into the demand of buyers in the stock, the three exhibitions will be held concurrently, including Medtec China, ADTE (Advanced Active Device Tech EXPO) and Quality Expo, which will attract more new visitors from the application industry and create unlimited business opportunities for exhibitors. The early bird price will end in 2 days! Click to exhibit now! Medtec China 2024 has seen an optimization and upgrade in terms of the layout of the exhibiting zones and exhibits, where 16 exhibiting zones will be accommodated in two halls, Medical Manufacturing Services & Equipment Hall and Medical Materials & Core Components Hall. The layout of exhibiting zone is constantly optimized, with the former Medical Regulation Street and Medical Regulatory Street merged into the Consulting Service (Medical Regulations, CDMO, CSO) Zone, and the Automation Zone upgraded into the Zone of Medical Integration & Automation, Drive Control, and Robotics. The size of the popular exhibiting zones continues to expand, from the Raw Materials (Polymer/Combined Materials) and Components Zone, the Zone of Metallic Materials & Metal Parts, Ceramics and Related processes, the Adhesives & Adhesive Products Zone, to the Tubing and Extrusion Products Zone. A wide spectrum of medical enterprises have already exhibited, including Lubrizol, Momentive Performance Materials Inc., Avantor NuSil, DuPont, Americhem, Henkel, Alders, Hanarey Chemicals, Polymer Science, Fort Wayne Metals, TANAKA Precious Metals, HRJ Precision Extrusion Machinery , ELGILOY, Changzhou JWELL Pipe Equipment. Click to download the floorplan 2024 . The Advanced Active Device Tech EXPO will showcase a wide range of products, including chips, sensors, integrated circuits, connectors, power supplies and motors, software, AI, 5G smart medical care, imaging equipment core parts, surgical robot, optical components, endoscopic parts, lasers, imaging solutions, etc. Confirmed exhibitors include Lemo Electronics, ZheJiang Quark-Med, Tide Smart, Beijing Vince, Shenzhen Ojos, Shanghai FuAn Biomechatronics, Beijing Rongyuan, Guangzhou Wiserscope, SUZHOU SINAN SENSOR TECHNOLOGY, Dongguan Ching Tai Electric Wire&cable, Hangzhou Tongjian Technology, YW MEMS, Shanghai BIX Electronics and so on. There are still a few seats available, Click to enjoy the early bird price. As a resource exchange platform for forging quality managers, Quality Expo China gathers outstanding suppliers of testing, measurement, inspection, and calibration equipment and supplies at home and abroad. Moreover, there are also multiple quality conferences available to build industry-academia-research integrated platform. Exhibited enterprises at present include Carl Zeiss, KEYENCE, Starrett Tools, OGP, MARPOSS, USON China, ANHUI WANYI, Hengyi Weighing & Instrument, Cincinnati, Shenyang Golden Tech, UPTON Technology, etc., with the joint commitment of safeguarding the quality control of medical devices after mass production. Pre-Exhibition Meeting firstly Debut to Facilitate Industry Dialogue, 100+ Trend-setting Education and Industry Keynote Speakers Get Together at Medtec China to Share Industry Highlights The MDiT Forum Summit 2024 and Concurrent Activities and the Medtec Medical Device Design and Manufacturing Technology Industry Summit will be held in Medtec China 2024, with nearly 100 concurrent events to bring manufacturing professionals together to look into the future of the industry. In the form of "Main Forum + Sub-Forum", pre-exhibition meeting Medtec Medical Device Design & Manufacturing Technology Industry Summit will invite representatives from regulatory agencies, hospitals, and research institutes to deliver keynote speeches in four segments, regulation, quality, integration of medical engineering , and active devices. Covering all aspects of design, processing, manufacturing, regulations, and testing, MDiT Forum Summit 2024 and Concurrent Activities will discuss the industry trends and technological innovations to provide deeper insights and drive continuous progress in the industry. Medtec China 2024 plans a pre-exhibition meeting in the form of a "Main Forum + Sub-Forum" to discuss the four hot topics based on regulations, quality, integration of medical engineering and active device. Experts in the fields of regulation and quality will be invited to share their unique insights or latest studies ideas, who will use their years of experience to help enhance the safety and effectiveness of medical devices. In active device forum, Medtec China 2024 will focus on the core technology of endoscopy, imaging, electrophysiology. And integration of medical engineering forum will bring the actual cases of clinical application from a doctor's perspective, accelerating the process of product design, R & D and transformation of manufacturing enterprises. Meanwhile, Medtec China 2024 will concurrently hold MDiT Forum Summit 2024 and Concurrent Activities, with technical topics focusing on "Innovative Medical Materials/Accessories and Precision", "High polymer Material Application in Medical Devices", "Technology of Medical Bonding and Welding", "Pack&Ster Hub", "Precision machining equipment and Technology" , "Technology Development of New Type Medical Dressings" and so on. The conferences and speakers are being planned and recruited and look forward to the participation of industry opinion leaders from medical device manufacturing enterprises, medical institutions, universities, and research institutions. Click here to exhibit and customize private speech. As an exhibition dedicated to the design and manufacturing of medical devices, Medtec China has continued to explore the industry hotspots and open new tracks for 20 years since 2005. Medtec China 2024 will launch activities to celebrate the 20th anniversary, including the 20th anniversary theme logo and opening ceremony, 20 years of growth history, etc. Onsite activities include VIP business banquets, exhibitor interviews and live streaming, on-site exhibitor interviews and live broadcasts, Media Live and more. Click to participate in the 20th anniversary industry event and embrace the future together! Medtec China 2024 will be held at H1 & H2 in the Shanghai World Expo Exhibition & Convention Center from September 25 to 27, and it will gather 1,000+ high-quality suppliers from 27 countries across the globe. Meanwhile, a varied range of activities will be presented at the 20th anniversary of Medtec China, where will be full of unlimited business opportunities. Click to exhibit and enjoy the early-bird price now. For more details, please visit Medtec China at: en.medtecchina.com to get the latest exhibition information and cutting-edge industry articles.
PERTH, Australia, March 9, 2026 /PRNewswire/ -- Pela Global Limited ("PELA" or "the Company") is pleased to announce that, following a rigorous application and approval process, the Company has executed a Project Development Funding Agreement (Agreement) with the U.S. International Development Finance Corporation (DFC). The Agreement provides up to US$5 million in project development funding to support and advance PELA's flagship Krstov Dol Antimony Mine Restart Project (KDM) in North Macedonia. The funding represents a significant milestone in PELA's strategy to become a near-term supplier of critical minerals to allied markets. The Agreement provides funding support for defined project development activities at KDM, including the preparation of a Mineral Resource Estimate to be reported in accordance with the JORC Code, completion of an Environmental and Social Impact Assessment, and progression of the project toward feasibility. The project is underpinned by historical mining activity and a substantial body of historical geological and technical data, including historical mineral resource and reserve estimates prepared and approved under the former Yugoslav reporting system. About Pela Global Limited Pela Global Limited is an Australian critical and precious metals company focused on the responsible development of mineral resources across Southeastern Europe's Tethyan Metallogenic Belt. Its key assets include: Krstov Dol Antimony Project (North Macedonia) – An advanced-stage project aiming to produce high-grade antimony concentrate from a historically producing site, strategically positioned to support Western critical minerals supply objectives. Samar Gold Project (North Macedonia) – A high-grade polymetallic system with confirmed gold, silver, lead, zinc, and copper mineralisation, offering strong exploration and development potential. Pela's board of directors is pleased to advise that it is currently considering the opportunity to undertake an initial public offering of its shares (IPO) in support of an application for admission to an Australian securities exchange. If the board determines to proceed with an IPO, Pela will make available a prospectus with the full terms and other details of the IPO. While there is no guarantee that the IPO will necessarily proceed, the Company will look to provide updates in this regard on its website and/or by email. For more information, visit www.pelaglobal.com.
NEW YORK, Jan. 2, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. NYSE Content Advisory: Pre-Market update + 2026 Trading Begins after the S&P 500’s Strong 2025 Kristen Scholer delivers the pre-market update on January 2nd Tech stocks, especially AI names, are lifting the S&P 500 early in the first trading session of the year. Precious metals are also higher after silver and gold posted big gains in 2025. The S&P 500 finished last year up 16%, marking a third consecutive year of double-digit gains. Strategists expect continued strength amid economic resilience. Historically bullish year-end trend hasn't fully materialized—the S&P fell 0.9% in the last five sessions of 2025, but today's 0.6% gain suggests momentum may be turning. Opening BellRobin Hood rings the NYSE Opening Bell Closing BellNextGen EMP celebrates their one-year anniversary Click here to download the NYSE TV App
TORONTO and PERTH, Australia, June 23, 2025 /PRNewswire/ -- Kinterra Capital GP Corp. II ("Kinterra"), in its capacity as general partner of the Kinterra Critical Materials & Infrastructure Opportunities Fund II, LP, confirms that it has submitted a non-binding, indicative proposal to acquire 100% of the shares in New World Resources Limited (ASX: NWC) ("New World" or the "Company") for an all cash consideration of A$0.057 per share ("Kinterra Proposal"). The Kinterra Proposal is subject to a very short period of confirmatory due diligence, and to limited other conditions, including no regulatory conditions. Kinterra believes the Kinterra Proposal is in the best interest of New World shareholders and represents a Superior Proposal to the revised agreement entered into by New World and Central Asia Metals Plc (LON: CAML) on June 20, 2025. In addition, Kinterra currently has a 19.16% relevant interest in NWC shares, making it highly unlikely that the proposed CAML scheme will be successful. Kinterra looks forward to constructive engagement with the New World Board of Directors over an expedited timeline. About Kinterra Capital Kinterra Capital is a private equity firm that invests in the people, ideas, critical materials, and strategic infrastructure necessary to accelerate the development of the modern economy. Kinterra leverages significant domain specific technical and transactional expertise to source and manage investments that create value for its stakeholders, all while supporting the communities within which we operate through meaningful partnerships. At Kinterra, we focus on creative ideation, rigorous analysis and executing with excellence to make investments that will create sustainable, strong and secure supply chains. For more information about Kinterra Capital, please visit www.kinterracapital.com. Logo - https://mma.prnasia.com/media2/2716229/Kinterra_Capital_Corp_Kinterra_Capital_Submits_Proposal_to_Acqui.jpg?p=medium600
PENANG, Malaysia, June 6, 2025 /PRNewswire/ -- Quantum Metal Recovery Inc. (QMRI), the largest shareholder of Besra Gold Inc. (Besra), has issued a formal response to Besra's 22 May 2025 ASX announcement titled "Market Update: Clarification of Quantum Presentation" and its accompanying Management Information Circular. QMRI disagrees entirely with the contents of both documents, describing them as partisan, inflammatory, and, in some instances, potentially defamatory. On 15 May 2025, QMRI initiated legal proceedings in the Superior Court of Justice (Ontario), seeking relief related to its ongoing effort to replace Besra's incumbent board. The Notice of Application is publicly filed and available here. QMRI intends to pursue this effort either through the scheduled shareholders' meeting or by court order. As part of its continued commitment to shareholder interests, QMRI has nominated three independent directors with extensive mining industry experience: Mr. David Izzard, a Certified Practicing Accountant and experienced board director with strong commercial, strategic, and financial management background in listed companies. Dr. Matthew Greentree, a mining executive and geologist with over 25 years in exploration and development, formerly Managing Director and CEO of Ausgold Limited. Dr. William John Blake, a qualified Mining Engineer and former CEO with over 35 years of international experience in mining operations across Asia-Pacific and the Americas. Contrary to the Management Circular, QMRI's nominees to the board of Besra are at arm's length to QMRI and Dato Lim and were independently selected by an executive recruitment agency for their industry experience and specialised knowledge in international mining projects, including gold projects. Despite Besra's recent interim board appointments, QMRI expresses concern that meaningful progress on the Bau Gold Project has stalled. It believes its proposed nominees will bring transparency, expertise, and effective oversight to realign the company with its contractual obligations and shareholder expectations. To view the full statement and supporting details, including the legal filing, please click here. Media Contact: Corporate Communications DepartmentQuantum Metals Recovery Inc.qmri.press@gmail.com
LONDON, and SINGAPORE, May 23, 2024 /PRNewswire/ -- Bulk commodity trader, Ores & Minerals, announces a victory in arbitration against Anh Son Thuy, a company nominated by industrial group Hoa Phat, Singapore. Hoa Phat's nominated entity, Anh Son Thuy must pay Ores & Minerals $1,473,802.48 in arbitration, as ruled by The Singapore International Arbitration Centre on 2nd May 2023, due to violations in deadfreight, demurrage, and detention. The dispute stems from a contractual agreement between Ores & Minerals and Anh Son Thuy for the transportation of a cargo consisting of 50,000 metric tons of iron ore pellet chips and fines. Despite explicit contractual terms and industry-standard practices, Hoa Phat Singapore's nominated Anh Son Thuy's actions led to substantial deadfreight costs and associated damages, causing non-performance and breach of contract. As a company committed to integrity, transparency, and fair business practices, Ores & Minerals underscores the importance of upholding contractual obligations and fostering trust within the global business community. Final Arbitration Award can be found here Ores & Minerals extends its appreciation to the tribunal for its diligent review of the case. Final Arbitration AwardRegistered in SIAC Registry of Awards as: Award No. 062 of 2023For media inquiries or further information, please contact Ores Minerals UK on +44 2037 519 391 Ores & Minerals Corporation is an International Commodity Trading Group acting as trader and merchant, primarily in metals and minerals, obtained through direct relationships with mine owners, aggregators, refiners, processors and fabricators around the world.
A12 藝術空間
Metals
請先登入後才能發佈新聞。
還不是會員嗎？立即 加入台灣產經新聞網會員 ，使用免費新聞發佈服務。 （服務項目） （投稿規範）
